Abstract

Genomic instability is a fundamental feature of human cancer often resulting from impaired genome maintenance. In prostate cancer, structural genomic rearrangements are a common mechanism driving tumorigenesis. However, somatic alterations predisposing to chromosomal rearrangements in prostate cancer remain largely undefined. Here, we show that SPOP, the most commonly mutated gene in primary prostate cancer, modulates DNA double strand break (DSB) repair, and that SPOP mutation is associated with genomic instability. In vivo, SPOP mutation results in a transcriptional response consistent with BRCA1 inactivation resulting in impaired homology-directed repair (HDR) of DSB. Furthermore, we found that SPOP mutation sensitizes to DNA damaging therapeutic agents such as PARP inhibitors. These results implicate SPOP as a novel participant in DSB repair, suggest that SPOP mutation drives prostate tumorigenesis in part through genomic instability, and indicate that mutant SPOP may increase response to DNA damaging therapeutics.

Article and author information

Author details

  1. Gunther Boysen

    Department of Pathologygy and Laboratory Medicine, Weill Cornell Medical College, New York, United Kingdom
    Competing interests
    No competing interests declared.
  2. Christopher E Barbieri

    Department of Urologygy, Weill Cornell Medical College, New York, United States
    Competing interests
    Christopher E Barbieri, A patent (US Patent Application No: 2013/0331,279) has been issued to Weill Medical College of Cornell University on SPOP mutations in prostate cancer; is listed as co-inventor.
  3. Davide Prandi

    Centre for Integrative Biologygy, University of Trento, Trento, Italy
    Competing interests
    No competing interests declared.
  4. Mirjam Blattner

    Department of Pathologygy and Laboratory Medicine, Weill Cornell Medical College, New York, United States
    Competing interests
    No competing interests declared.
  5. Sung-Suk Chae

    Department of Pathologygy and Laboratory Medicine, Weill Cornell Medical College, New York, United States
    Competing interests
    No competing interests declared.
  6. Arun Dahija

    Department of Pathologygy and Laboratory Medicine, Weill Cornell Medical College, New York, United States
    Competing interests
    No competing interests declared.
  7. Srilakshmi Nataraj

    Department of Pathologygy and Laboratory Medicine, Weill Cornell Medical College, New York, United States
    Competing interests
    No competing interests declared.
  8. Dennis Huang

    Department of Pathologygy and Laboratory Medicine, Weill Cornell Medical College, New York, United States
    Competing interests
    No competing interests declared.
  9. Clarisse Marotz

    Department of Pathologygy and Laboratory Medicine, Weill Cornell Medical College, New York, United States
    Competing interests
    No competing interests declared.
  10. Limei Xu

    Department of Pathologygy and Laboratory Medicine, Weill Cornell Medical College, New York, United States
    Competing interests
    No competing interests declared.
  11. Julie Huang

    Department of Pathologygy and Laboratory Medicine, Weill Cornell Medical College, New York, United States
    Competing interests
    No competing interests declared.
  12. Paola Lecca

    Centre for Integrative Biologygy, University of Trento, Trento, Italy
    Competing interests
    No competing interests declared.
  13. Sagar Chhangawala

    Department of Surgery, Weill Cornell Medical College, New York, United States
    Competing interests
    No competing interests declared.
  14. Deli Liu

    Department of Urologygy, Weill Cornell Medical College, New York, United States
    Competing interests
    No competing interests declared.
  15. Pengbo Zhou

    Department of Pathologygy and Laboratory Medicine, Weill Cornell Medical College, New York, United States
    Competing interests
    No competing interests declared.
  16. Andrea Sboner

    Department of Pathologygy and Laboratory Medicine, Weill Cornell Medical College, New York, United States
    Competing interests
    No competing interests declared.
  17. Johann S de Bono

    Division of Clinical Studies, Institute of Cancer Research, London, United Kingdom
    Competing interests
    No competing interests declared.
  18. Francesca Demichelis

    Centre for Integrative Biologygy, University of Trento, Trento, Italy
    Competing interests
    No competing interests declared.
  19. Yariv Houvras

    Department of Surgery, Weill Cornell Medical College, New York, United States
    Competing interests
    No competing interests declared.
  20. Mark A Rubin

    Department of Pathologygy and Laboratory Medicine, Weill Cornell Medical College, New York, United States
    For correspondence
    rubinma@med.cornell.edu
    Competing interests
    Mark A Rubin, A patent (US Patent Application No: 2013/0331,279) has been issued to Weill Medical College of Cornell University on SPOP mutations in prostate cancer; is listed as co-inventor.

Reviewing Editor

  1. Joaquín M Espinosa, University of Colorado at Boulder, United States

Ethics

Animal experimentation: All protocols were performed with prior approval of the WCMC IACUC under protocol 2012-0065.

Version history

  1. Received: June 3, 2015
  2. Accepted: September 16, 2015
  3. Accepted Manuscript published: September 16, 2015 (version 1)
  4. Version of Record published: October 27, 2015 (version 2)

Copyright

© 2015, Boysen et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 7,178
    views
  • 1,441
    downloads
  • 139
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Gunther Boysen
  2. Christopher E Barbieri
  3. Davide Prandi
  4. Mirjam Blattner
  5. Sung-Suk Chae
  6. Arun Dahija
  7. Srilakshmi Nataraj
  8. Dennis Huang
  9. Clarisse Marotz
  10. Limei Xu
  11. Julie Huang
  12. Paola Lecca
  13. Sagar Chhangawala
  14. Deli Liu
  15. Pengbo Zhou
  16. Andrea Sboner
  17. Johann S de Bono
  18. Francesca Demichelis
  19. Yariv Houvras
  20. Mark A Rubin
(2015)
SPOP mutation leads to genomic instability in prostate cancer
eLife 4:e09207.
https://doi.org/10.7554/eLife.09207

Share this article

https://doi.org/10.7554/eLife.09207

Further reading

    1. Cell Biology
    2. Structural Biology and Molecular Biophysics
    Marcel Proske, Robert Janowski ... Dierk Niessing
    Research Article

    Mutations in the human PURA gene cause the neurodevelopmental PURA syndrome. In contrast to several other monogenetic disorders, almost all reported mutations in this nucleic acid-binding protein result in the full disease penetrance. In this study, we observed that patient mutations across PURA impair its previously reported co-localization with processing bodies. These mutations either destroyed the folding integrity, RNA binding, or dimerization of PURA. We also solved the crystal structures of the N- and C-terminal PUR domains of human PURA and combined them with molecular dynamics simulations and nuclear magnetic resonance measurements. The observed unusually high dynamics and structural promiscuity of PURA indicated that this protein is particularly susceptible to mutations impairing its structural integrity. It offers an explanation why even conservative mutations across PURA result in the full penetrance of symptoms in patients with PURA syndrome.

    1. Cell Biology
    Mathieu C Husser, Nhat P Pham ... Alisa Piekny
    Tools and Resources

    Endogenous tags have become invaluable tools to visualize and study native proteins in live cells. However, generating human cell lines carrying endogenous tags is difficult due to the low efficiency of homology-directed repair. Recently, an engineered split mNeonGreen protein was used to generate a large-scale endogenous tag library in HEK293 cells. Using split mNeonGreen for large-scale endogenous tagging in human iPSCs would open the door to studying protein function in healthy cells and across differentiated cell types. We engineered an iPS cell line to express the large fragment of the split mNeonGreen protein (mNG21-10) and showed that it enables fast and efficient endogenous tagging of proteins with the short fragment (mNG211). We also demonstrate that neural network-based image restoration enables live imaging studies of highly dynamic cellular processes such as cytokinesis in iPSCs. This work represents the first step towards a genome-wide endogenous tag library in human stem cells.